Proceedings of the 49th Annual ASTRO Meeting
A13
STATEMENT OF NEED Advances in the applications, technologies and methodologies of radiation oncology continue to evolve and expand rapidly, creating a need for continual learning. The 2007 Annual Meeting Scientific Program is designed to disseminate new scientific findings and technical innovations and to expand basic knowledge relevant to clinical practice and to the improvement of patient outcomes.
PROGRAM DESCRIPTION AND OBJECTIVES The program will include presentations on standard, investigational and experimental therapeutics, brachytherapy, intraoperative radiation therapy, particle radiotherapy, image guided radiation therapy, intensity modulated radiation therapy, treatment planning, alternative fractionation, emerging technologies, and molecular and radiation biology. Specific clinical areas include breast, central nervous system, gastrointestinal, genitourinary, gynecological, head and neck, lung, lymphoma, musculoskeletal, pediatric and thoracic cancers. This year’s program will emphasize prevention, organ and function preservation, quality of life, supportive care and end-of-life issues. Information on healthcare policy, health services research and cancer disparities will also be addressed. These topics are addressed by a combination of educational sessions, panel discussions, proffered papers and posters. Educational sessions provide attendees with an essential review of timely topics. Panel discussions emphasize current controversies. Proffered papers and poster presentations represent new research findings. This combination provides complementary coverage of a broad range of topics relevant to radiation oncology and members of the multidisciplinary cancer care team.
TARGET AUDIENCE The educational elements of this program are targeted at oncologists of all disciplines, physicists, biologists, nurses, therapists, dosimetrists and other allied health professionals involved in radiation therapy. Attendees will receive state-of-the-art practice information relating to radiation, surgical and medical oncology. Embracing the multidisciplinary approach to cancer care is essential to quality care. Research presented from medical and surgical oncologists, pathologists and allied professionals will enhance the interdisciplinary nature of the program.
CONTINUING MEDICAL EDUCATION PHYSICIANS The American Society for Therapeutic Radiology and Oncology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society for Therapeutic Radiology and Oncology designates this educational activity for a maximum of 34.75 AMA PRA Category 1 credits.Ô Physicians should only claim credit commensurate with the extent of their participation in the activity. TECHNOLOGISTS Application has been made to the American Society for Radiologic Technologists for designation of Category A continuing education credit. DOSIMETRISTS Application has been made to the Medical Board of Certified Dosimetrists for designation of MBCD credits. NURSES The Oncology Nursing Society (ONS) is accredited as an approver of continuing education for nurses by the American Nurses Credentialing Center’s Commission on Accreditation. Application has been made to ONS for CEU credits.
A14
I. J. Radiation Oncology d Biology d Physics
Volume 69, Number 3, Supplement, 2007
PHYSICISTS Application has been made to the Commission on Accreditation of Medical Physics Education Program for CAMPEP credits. DISCLOSURE OF VESTED INTEREST In addition to written disclosure, presenters will disclose any vested interest or their intention to discuss off-label use of pharmaceuticals or devices, if applicable, to the audience at the beginning of their presentation in accordance with the Accreditation Council for Continuing Medical Education and the Food and Drug Administration requirements.
This information contained in this program is subject to change. Updates to the program faculty and schedule will be made available online at www.astro.org.